By Adriano Marchese
Enovis said Wednesday that its chief executive officer, Matt Trerotola, is set to retire and will step down from the role after the company finds a successor.
The medical technology said it has begun to work with an executive search firm to identify a new industry leader.
Once the company finds a candidate to succeed in the CEO role, Enovis and Trerotola will enter into a retirement and transition agreement whereby Trerotola will continue to serve as an employee and executive advisor for a one-year period to help with a smooth transition of responsibilities.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
February 26, 2025 06:15 ET (11:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.